Paras Singh Chandi

Appearances

DEVELOPMENT AND VALIDATION OF A MACHINE LEARNING (ML) BASED DECISION-MAKING TOOL TO DETERMINE RISK AND TIMING OF RECURRENCE OF BARRETT’S ESOPHAGUS (BE) NEOPLASIA AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY (EET)
Date
May 18, 2024
Recent studies have described the durability of EET for BE-related neoplasia and the risk of neoplastic recurrence after achieving complete eradication of intestinal metaplasia (CE-IM). Current guidelines for endoscopic surveillance intervals post-EET are based on limited evidence…
Presenter
Venkata Akshintala
Johns Hopkins Hospital
Speakers
Samuel Han
Yukun Yan
Case Brennan
Paras Singh Chandi
Cary Cotton
Dayna Early
Washington University in St. Louis
Steven Edmundowicz
University of Colorado School of Medicine
Swathi Eluri
University of North Carolina at Chapel Hill School of Medicine
Jazmyne Gallegos
Rohit Goyal
Hazem Hammad
Thomas Hollander
Prasad Iyer
Mayo Clinic
Justeena Jojo
Sri Komanduri
Northwestern University
Vladimir Kushnir
Washington University School of Medicine
V. Raman Muthusamy
Amit Rastogi
Nicholas Shaheen
Adarsh Thaker
UCLA
Craig Jones
Sachin Wani
University of Colorado